We tested the hypothesis that heart rate (HR) reduction with ivabradine (IVA) leads to reversal of structural, biochemical, and molecular maladaptations characteristic of the heart failure (HF) state. HR reduction with IVA has been shown to improve left ventricular (LV) systolic function and clinical outcome in patients with HF.Studies were performed in 16 HF dogs produced by intracoronary microembolizations [LV ejection fraction (EF) ~35
作者:Hani N, Sabbah;Ramesh C, Gupta;Smita, Kohli;Mengjun, Wang;Kefei, Zhang;Sharad, Rastogi
来源:ESC heart failure 2014 年 1卷 2期